The EFM19 (ER+/HER2−; PIK3CA mt) breast cancer cell line was conditioned through long-term exposure to increasing concentrations of palbociclib until the cells continued to proliferate in the presence of drug at concentrations greater than the cellular IC50 (78 nmol/L) (Fig. 1a). Here, ERBB2 is linked to breast carcinoma.